Patents by Inventor Michel Maillard

Michel Maillard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090270367
    Abstract: The invention relates to novel compounds and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
    Type: Application
    Filed: March 3, 2009
    Publication date: October 29, 2009
    Inventors: Varghese JOHN, Michel MAILLARD, John TUCKER, Jose AQUINO, Barbara JAGODZINSKA, Louis BROGLEY, Jay TUNG, Simeon BOWERS, Darren DRESSEN, Gary PROBST, Neerav SHAH
  • Publication number: 20090074746
    Abstract: The present invention is substituted amines of formula (X) useful in treating Alzheimer's disease and other similar diseases.
    Type: Application
    Filed: September 24, 2004
    Publication date: March 19, 2009
    Inventors: Lawrence Y. Fang, Roy Hom, Varghese John, Michel Maillard
  • Patent number: 7498436
    Abstract: This present invention relates to prodrug compounds of the formula (Y) and pharmaceutical salts thereof: where RN, R1, R2, R3R4 and RC are defined herein, which are useful in treating Alzheimer's disease and other similar diseases.
    Type: Grant
    Filed: February 27, 2003
    Date of Patent: March 3, 2009
    Assignees: Pharmacia & Upjohn Company LLC, Elan Pharmaceuticals, Inc.
    Inventors: Varghese John, Barbara Jagodzinska, Michel Maillard, James P. Beck, Ruth E. TenBrink, Daniel Getman
  • Publication number: 20090042961
    Abstract: The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
    Type: Application
    Filed: May 8, 2008
    Publication date: February 12, 2009
    Inventors: Varghese John, Michel Maillard, Barbara Jagodzinska, Jose Aquino, Gary Probst, Jay Tung
  • Publication number: 20080298585
    Abstract: A method for securing a portable security module for use with a decoding element, the portable security module and the decoding element allowing to descramble scrambled audiovisual information. The method comprises analyzing at the portable security module a sequence of command messages, the command messages of the sequence being received at the portable security module at distinct times.
    Type: Application
    Filed: February 18, 2005
    Publication date: December 4, 2008
    Applicant: Canal + Technologies
    Inventors: Michel Maillard, Le Floch Dominique
  • Patent number: 7454618
    Abstract: A method for transmitting information between a transmitter station and a plurality of receiving stations in which encrypted information is transmitted from the transmitter station to the receiver station with a first key and at least a control message bearing a second key. The first key used for decryption is restored in each receiving station from the second key and from at least one datum selected from a set of data available in the receiving stations, according to a selection command periodically transmitted between the transmitting station and the receiving station. Such a system may find particular application to pay television.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: November 18, 2008
    Assignee: Nagra Thomson Licensing
    Inventors: Jean-Luc Dauvois, Michel Maillard
  • Patent number: 7385085
    Abstract: The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
    Type: Grant
    Filed: July 11, 2005
    Date of Patent: June 10, 2008
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: Varghese John, Michel Maillard, Barbara Jagodzinska, Jose Aquino, Gary Probst, Jay Tung
  • Publication number: 20080096942
    Abstract: Disclosed are compounds of the formula and the pharmaceutically acceptable salts thereof wherein the variables G, L, A, W, E, R2, R2, R4, R5, RN, and RC are defined herein. These compounds interact with and inhibit the activity of the enzyme beta-secretase. These compounds are therefore useful in treating Alzheimer's disease and other similar diseases. Pharmaceutical compositions and methods of treatment of these diseases are also disclosed.
    Type: Application
    Filed: December 21, 2007
    Publication date: April 24, 2008
    Inventors: Ruth Tenbrink, Michel Maillard, Martha Warpehoski
  • Patent number: 7361688
    Abstract: The invention provides compounds of formula (I): useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal.
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: April 22, 2008
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: Michel Maillard, John A. Tucker
  • Patent number: 7312360
    Abstract: Disclosed are compounds of the formula and the pharmaceutically acceptable salts thereof wherein the variables G, L, A, W, E, R2, R3, R4, R5, RN, and Rc are defined herein. These compounds interact with and inhibit the activity of the enzyme beta-secretase. These compounds are therefore useful in treating Alzheimer's disease and other similar diseases. Pharmaceutical compositions and methods of treatment of these diseases are also disclosed.
    Type: Grant
    Filed: December 6, 2002
    Date of Patent: December 25, 2007
    Assignees: Elan Pharmaceuticals, Inc., Pharmacia & Upjohn Company
    Inventors: Ruth TenBrink, Michel Maillard, Martha Warpehoski
  • Publication number: 20070293483
    Abstract: Disclosed are compounds of the formula: where variables Z, X, R15, R2, R3, and Rc are defined herein. Compounds disclosed herein are inhibitors of the beta-secretase enzyme and are therefore useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal.
    Type: Application
    Filed: June 6, 2006
    Publication date: December 20, 2007
    Inventors: Varghese John, Michel Maillard, James Beck, Eric Baldwin, Robert Hughes, Shon Pulley, Ruth TenBrink
  • Publication number: 20070213316
    Abstract: Disclosed are compounds of the formula wherein the variables RN, RC, R1, R25, R2, and R3 are as defined herein. These compounds have activity as inhibitors of beta-secretase and are therefore useful in treating a variety of discorders such as Alzheimer's Disease.
    Type: Application
    Filed: December 11, 2006
    Publication date: September 13, 2007
    Inventors: Varghese John, Michel Maillard, Barbara Jagodzinska, James Beck, Andrea Gailunas, John Freskos, John Mickelson, Lakshman Samala, Jennifer Sealy, Ruth TenBrink, Lawrence Fang, Roy Hom
  • Publication number: 20070213407
    Abstract: The present invention is substituted amines of formula (X) useful in treating Alzheimer's disease and other similar diseases.
    Type: Application
    Filed: September 28, 2006
    Publication date: September 13, 2007
    Inventors: Lawrence Fang, Andrea Gailunas, Roy Hom, Barbara Jagodzinska, Michel Maillard, Varghese John, Shon Pulley, James Beck, Ruth TenBrink, John Freskos
  • Patent number: 7244725
    Abstract: Disclosed are compounds of the formula: where variables Z, X, R15, R2, R3, and RC are defined herein. Compounds disclosed herein are inhibitors of the beta-secretase enzyme and are therefore useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal.
    Type: Grant
    Filed: September 10, 2003
    Date of Patent: July 17, 2007
    Assignees: Elan Pharmaceuticals, Inc., Pharmacia & Upjohn Company
    Inventors: Varghese John, Michel Maillard, James P. Beck, Eric T. Baldwin, Robert Hughes, Shon R. Pulley, Ruth TenBrink
  • Patent number: 7239704
    Abstract: A method relating to recording transmitted digital data in which transmitted digital information is encrypted by a recording encryption key. The recording encryption key is stored by a recording means on a recording support medium. Further, the recording encryption key is characterized in that an equivalent of the recording encryption key is encrypted by a recording transport key, which is also stored on the support medium with the encrypted information.
    Type: Grant
    Filed: February 11, 1999
    Date of Patent: July 3, 2007
    Assignee: Thomson Licensing S.A.
    Inventors: Michel Maillard, Christian Benardeau
  • Publication number: 20070149584
    Abstract: The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
    Type: Application
    Filed: July 11, 2005
    Publication date: June 28, 2007
    Inventors: Varghese John, Michel Maillard, Barbara Jagodzinska, Jose Aquino, Gary Probst, Jay Tung
  • Publication number: 20070113073
    Abstract: A method of secure communication of digital data between devices, including validating, by a security module, the devices using device identifiers, generating a random key in the security module, and transmitting the random key to the devices.
    Type: Application
    Filed: December 8, 2006
    Publication date: May 17, 2007
    Applicant: THOMSON Licensing S.A.
    Inventors: Michel Maillard, Jean-Luc Dauvois, Frederic Dublanchet, David Leporini
  • Patent number: 7214715
    Abstract: The present invention is substituted amines of formula (X) and of the formula (X?) useful in treating Alzheimer's disease and other similar diseases.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: May 8, 2007
    Assignees: Pharmacia & Upjohn, Elan Pharmaceuticals
    Inventors: James P. Beck, Lawrence Y. Fang, John N. Freskos, Andrea Gailunas, Roy Hom, Barbara Jagodzinska, Varghese John, Michel Maillard, Shon R. Pulley, Ruth E. TenBrink
  • Publication number: 20070083756
    Abstract: A method of verification of rights is disclosed, contained in a security module associated to an apparatus processing broadcasted digital data. The apparatus is connected to a management center transmitting encrypted rights messages for accessing the digital data. The method includes reception and reading by the security module of all or part of a rights message including at least one right and means for verifying the right, decryption and verification of the rights message and updating of a rights memory, and storage of all or part of the rights message in a messages memory. During a further verification step, the method includes identification of at least one right present in the rights memory, search of the corresponding stored rights message and verification of the rights message, comparison of the right contained in the rights message with the corresponding right stored in the rights memory, and determination of a default state when the result of the comparison indicates a difference.
    Type: Application
    Filed: October 6, 2006
    Publication date: April 12, 2007
    Inventors: Dominique Le Floch, Michel Maillard
  • Patent number: RE40334
    Abstract: A method and apparatus for the transmission and reception of scrambled data is disclosed. In some embodiments, the method and apparatus includes transmitting a scrambled data stream to a decoder, sending the scrambled data stream to a portable security module inserted in the decoder, descrambling the scrambled data stream, encrypting a descrambled data stream, and using the encrypted data stream to the decoder, decrypting the encrypted data stream, and using the decrypted data stream.
    Type: Grant
    Filed: January 13, 2006
    Date of Patent: May 20, 2008
    Assignee: Nagra Thomson Licensing
    Inventors: Michel Maillard, Christian Benardeau, Jean-Luc Dauvois